SCHEMBL247684

SCHEMBL247684

CCCCCCOC(=O)c1ccccc1CC

nearest known ligand 0.81

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.81
TSHR P16473 5/20 0.81
LMNA P02545 3/20 0.81
MAPK1 P28482 3/20 0.78
CYP3A4 P08684 2/20 0.78
TP53 P04637 1/20 0.78
KDM4E B2RXH2 3/20 0.70
HSD17B10 Q99714 2/20 0.70
POLB P06746 1/20 0.70
L3MBTL1 Q9Y468 3/20 0.70
TDP1 Q9NUW8 2/20 0.70
MAPT P10636 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10889030 1.00 ALDH1A1 (0.81) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL10885387 1.00 ALDH1A1 (0.81) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL27770561 1.00 ALDH1A1 (0.81) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL10885092 0.98 TSHR (0.81) ALDH1A1TSHRLMNAMAPK1CYP3A4
Dimethylamine SCHEMBL10662569 0.95 ALDH1A1 (0.74) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL27392338 0.94 ALDH1A1 (0.87) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL9278581 0.93 TSHR (0.80) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL17797850 0.91 ALDH1A1 (0.68) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL17797862 0.91 ALDH1A1 (0.68) ALDH1A1TSHRLMNAMAPK1CYP3A4
SCHEMBL5407181 0.91 ALDH1A1 (0.77) ALDH1A1TSHRLMNAMAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 193 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113827507-A Sunscreen composition capable of phase inversion in use, preparation method and sunscreen cosmetic 南京阿奴生物科技有限公司 2021-12-24 CN claimed
US-9758637-B2 Blends of dibenzoate plasticizers EMERALD KALAMA CHEMICAL, INC. (US) 2017-09-12 US claimed
US-20160053085-A1 BLENDS OF DIBENZOATE PLASTICIZERS EMERALD KALAMA CHEMICAL, LLC 2016-02-25 US claimed
US-9193843-B2 Blends of dibenzoate plasticizers EMERALD KALAMA CHEMICAL, LLC (US) 2015-11-24 US claimed
US-20150038625-A1 MONOBENZOATE USEFUL AS A PLASTICIZER IN ADHESIVE PREPARATIONS EMERALD KALAMA CHEMICAL, LLC 2015-02-05 US claimed
WO-2014195055-A1 IMPROVEMENTS IN OR RELATING TO PLASTICISER ESTERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-11 WO claimed
EP-2810932-A1 Improvements in or relating to plasticiser esters ExxonMobil Chemical Patents Inc. (US) 2014-12-10 EP claimed
US-8258220-B2 Composition and method UNIQEMA AMERICAS LLC (US) 2012-09-04 US claimed
US-20100105803-A1 COMPOSITION AND METHOD CRODA UNIQEMA INC. (US) 2010-04-29 US claimed
EP-2132251-A2 COMPOSITION AND METHOD Croda Uniqema Inc (US) 2009-12-16 EP claimed
US-20080233067-A1 Method Of Making Enhanced Efficacy Antiperspirant Actives COLGATE-PALMOLIVE COMPANY (US) 2008-09-25 US claimed
WO-2008079304-A2 COMPOSITION AND METHOD CRODA UNIQEMA, INC. (US) 2008-07-03 WO claimed
US-7285519-B2 Oil production additive formulations CRODA INTERNATIONAL PLC (GB) 2007-10-23 US claimed
US-20030051395-A1 Oil production additive formulations IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2003-03-20 US claimed
EP-1292274-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES Colgate-Palmolive Company (US) 2003-03-19 EP claimed
EP-1235888-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2002-09-04 EP claimed
WO-2001097768-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES COLGATE-PALMOLIVE COMPANY (US) 2001-12-27 WO claimed
WO-2001040410-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2001-06-07 WO claimed
US-4305920-A FOR POLYMERIZATION CATALYST MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-15 US claimed
EP-4351531-A1 ENCAPSULATION OF LIVE MICROORGANISMS Tagra Biotechnologies Ltd (IL) 2024-04-17 EP disclosed
WO-2023114625-A1 POLYMER DISPERSION COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-22 WO disclosed
CN-114916284-A Treatment of plant seeds 盈可泰控股有限责任公司 2022-08-19 CN disclosed
US-11207333-B2 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy REGENERA PHARMA LTD. (IL) 2021-12-28 US disclosed
US-11173164-B2 Compositions comprising triterpenoids REGENERA PHARMA LTD. (IL) 2021-11-16 US disclosed
EP-3352742-B1 COMPOSITIONS COMPRISING TRITERPENOIDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE REGENERA PHARMA LTD (IL) 2021-11-03 EP disclosed
EP-3897527-A1 OXIDATIVE DYE IN RED SHADES WITH IMPROVED FASTNESS AND IMPROVED HOMOGENEITY Henkel AG & Co. KGaA (DE) 2021-10-27 EP disclosed
US-11083736-B2 Compositions comprising triterpenoids REGENERA PHARMA LTD. (IL) 2021-08-10 US disclosed
CN-109070547-B Polymer interlayers exhibiting enhanced properties and performance and multilayer sheets made therefrom 首诺公司 2021-07-20 CN disclosed
US-11000562-B2 Use of isolated fractions of mastic gum for treating optic neuropathy REGENERA PHARMA LTD. (IL) 2021-05-11 US disclosed
US-10806763-B2 Compositions of polymeric myrcene REGENERA PHARMA LTD. (IL) 2020-10-20 US disclosed
EP-3704134-A1 ANTIMICROBIAL TETRAPEPTIDES DSM IP Assets B.V. (NL) 2020-09-09 EP disclosed
US-10751347-B2 Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy REGENERA PHARMA LTD. (IL) 2020-08-25 US disclosed
WO-2020126225-A1 OXIDATIVE DYE IN RED SHADES WITH IMPROVED FASTNESS AND IMPROVED HOMOGENEITY HENKEL AG & CO. KGAA (DE) 2020-06-25 WO disclosed
US-20200155569-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2020-05-21 US disclosed
US-20200129396-A1 STYLING PRODUCT FOR HEAD HAIR AND/OR BEARD HAIR II HENKEL AG & CO. KGAA (DE) 2020-04-30 US disclosed
US-10588911-B2 Compositions comprising triterpenoids REGENERA PHARMA LTD. (IL) 2020-03-17 US disclosed
US-10561670-B2 Compositions comprising acidic extracts of mastic gum REGENERA PHARMA LTD. (IL) 2020-02-18 US disclosed
US-10475625-B2 Plasma treatment of liquid surfaces ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) 2019-11-12 US disclosed
US-20190314389-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2019-10-17 US disclosed
US-20190255132-A1 COMPOSTIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD. (IL) 2019-08-22 US disclosed
US-20190224216-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2019-07-25 US disclosed
US-20190224217-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2019-07-25 US disclosed
EP-3509699-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY Regenera Pharma Ltd. (IL) 2019-07-17 EP disclosed
EP-3509577-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY Regenera Pharma Ltd. (IL) 2019-07-17 EP disclosed
US-20190209582-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2019-07-11 US disclosed
US-20190192594-A1 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD. (IL) 2019-06-27 US disclosed
US-10307449-B2 Compositions of polymeric myrcene REGENERA PHARMA LTD. (IL) 2019-06-04 US disclosed
EP-2403512-B1 COMPOSITIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD (IL) 2019-05-15 EP disclosed
US-10285931-B2 Oxidative hair dye with optimized lift performance HENKEL AG & CO. KGAA (DE) 2019-05-14 US disclosed
US-10285996-B2 Compositions comprising triterpenoids REGENERA PHARMA LTD. (IL) 2019-05-14 US disclosed
EP-2613777-B1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD (IL) 2019-05-01 EP disclosed
US-10251923-B2 Therapeutic uses of mastic gum fractions REGENERA PHARMA LTD. (IL) 2019-04-09 US disclosed
US-20190076444-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2019-03-14 US disclosed
US-20190038529-A1 ODOR-REDUCING DEVELOPER FOR OXIDATION DYES II HENKEL AG & CO. KGAA (DE) 2019-02-07 US disclosed
US-10159680-B2 Compositions comprising acidic extracts of mastic gum REGENERA PHARMA LTD. (IL) 2018-12-25 US disclosed
US-20180264006-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2018-09-20 US disclosed
US-20180256603-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2018-09-13 US disclosed
CN-105102510-B Novel plasticizer blends and plastisol compositions comprising the same 艾默罗德卡拉玛化学品公司 2018-08-03 CN disclosed
EP-3352742-A1 COMPOSITIONS COMPRISING TRITERPENOIDS Regenera Pharma Ltd. (IL) 2018-08-01 EP disclosed
EP-3352767-A1 COMPOSITIONS COMPRISING TRITERPENOIDS Regenera Pharma Ltd. (IL) 2018-08-01 EP disclosed
US-20180071351-A1 USE OF ISOLATED FRACTIONS OF MASTIC GUM FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2018-03-15 US disclosed
WO-2018047175-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2018-03-15 WO disclosed
WO-2018047176-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2018-03-15 WO disclosed
US-20180064634-A1 OXIDATIVE HAIR DYE WITH OPTIMIZED LIFT PERFORMANCE HENKEL AG & CO. KGAA (DE) 2018-03-08 US disclosed
EP-3268020-A1 USE OF ISOLATED FRACTIONS OF MASTIC GUM FOR TREATING OPTIC NEUROPATHY Regenera Pharma Ltd. (IL) 2018-01-17 EP disclosed
US-20170368076-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2017-12-28 US disclosed
CN-107405372-A The separation fraction of frankincense gum is used for the purposes for treating optic neuropathy 瑞吉纳拉制药公司 2017-11-28 CN disclosed
US-9770456-B2 Compositions comprising acidic extracts of mastic gum REGENERA PHARMA LTD. (IL) 2017-09-26 US disclosed
US-20170252387-A1 COMPOSITIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD. (IL) 2017-09-07 US disclosed
US-9655938-B2 Compositions of polymeric myrcene REGENERA PHARMA LTD. (IL) 2017-05-23 US disclosed
WO-2017051423-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2017-03-30 WO disclosed
WO-2017051422-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2017-03-30 WO disclosed
US-20170036184-A1 PLASMA TREATMENT OF LIQUID SURFACES ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) 2017-02-09 US disclosed
EP-2403505-B1 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD (IL) 2016-12-07 EP disclosed
EP-2132251-B1 COMPOSITION AND METHOD CRODA AMERICAS LLC (US) 2016-10-12 EP disclosed
US-20160287654-A1 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD. (IL) 2016-10-06 US disclosed
WO-2016142936-A1 USE OF ISOLATED FRACTIONS OF MASTIC GUM FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2016-09-15 WO disclosed
US-20160199389-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2016-07-14 US disclosed
US-9364509-B2 Therapeutic uses of mastic gum fractions REGENERA PHARMA LTD. (IL) 2016-06-14 US disclosed
EP-2493461-B9 POLYMERIC MONOTERPENES FOR TREATING IMPAIRED NEUROLOGICAL FUNCTION REGENERA PHARMA LTD (IL) 2016-05-18 EP disclosed
US-9271949-B2 Compositions comprising acidic extracts of mastic gum REGENERA PHARMA LTD. (IL) 2016-03-01 US disclosed
US-20160017119-A1 NOVEL PLASTICIZER BLENDS AND PLASTISOL COMPOSITIONS COMPRISED THEREOF EMERALD KALAMA CHEMICAL, LLC 2016-01-21 US disclosed
EP-2970600-A1 NOVEL PLASTICIZER BLENDS AND PLASTISOL COMPOSITIONS COMPRISED THEREOF Emerald Kalama Chemical, LLC (US) 2016-01-20 EP disclosed
US-20160008291-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-01-14 US disclosed
EP-2493461-B1 POLYMERIC MONOTERPENES FOR TREATING IMPAIRED NEUROLOGICAL FUNCTION REGENERA PHARMA LTD (IL) 2016-01-06 EP disclosed
EP-2961433-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF Ramot at Tel-Aviv University Ltd. (IL) 2016-01-06 EP disclosed
US-20150246087-A1 EXTRACTS AND THERAPEUTIC USES THEREOF REGENERA PHARMA LTD. (IL) 2015-09-03 US disclosed
US-9067085-B2 Enhanced photoconductivity and SPF of semiconductors EVEREADY BATTERY COMPANY, INC (US) 2015-06-30 US disclosed
CN-104619430-A Monobenzoate useful as a plasticizer/coalescent in polymeric dispersions EMERALD KALAMA CHEMICAL LLC 2015-05-13 CN disclosed
US-20150110902-A1 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD. (IL) 2015-04-23 US disclosed
US-20150079021-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES REGENERA PHARMA LTD. 2015-03-19 US disclosed
US-8956601-B2 Therapeutic uses of mastic gum fractions REGENERA PHARMA LTD. (IL) 2015-02-17 US disclosed
US-20150025187-A1 MONOBENZOATE USEFUL AS A PLASTICIZER/COALESCENT IN POLYMERIC DISPERSIONS EMERALD KALAMA CHEMICAL, LLC (US) 2015-01-22 US disclosed
WO-2014195055-A1 IMPROVEMENTS IN OR RELATING TO PLASTICISER ESTERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-11 WO disclosed
EP-2810932-A1 Improvements in or relating to plasticiser esters ExxonMobil Chemical Patents Inc. (US) 2014-12-10 EP disclosed
US-20140294928-A1 COMPOSITIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD. (IL) 2014-10-02 US disclosed
WO-2014143902-A1 NOVEL PLASTICIZER BLENDS AND PLASTISOL COMPOSITIONS COMPRISED THEREOF EMERALD KALAMA CHEMICAL, LLC (US) 2014-09-18 WO disclosed
WO-2014132262-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-09-04 WO disclosed
US-8722105-B2 Compositions of polymeric myrcene REGENERA PHARMA LTD. (IL) 2014-05-13 US disclosed
WO-2013186766-A1 EXTRACTS AND THERAPEUTIC USES THEREOF REGENERA PHARMA LTD. (IL) 2013-12-19 WO disclosed
EP-2613777-A2 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM Regenera Pharma Ltd. (IL) 2013-07-17 EP disclosed
US-20130172416-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2013-07-04 US disclosed
WO-2013065051-A1 FORMULATION AND DEVICE FOR TREATING CERUMINOSIS NAVEH PHARMA (1996) LTD. (IL) 2013-05-10 WO disclosed
EP-2493461-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES Regenera Pharma Ltd. (IL) 2012-09-05 EP disclosed
US-8258220-B2 Composition and method UNIQEMA AMERICAS LLC (US) 2012-09-04 US disclosed
US-20120213727-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES REGENERA PHARMA LTD. (IL) 2012-08-23 US disclosed
WO-2012032523-A9 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2012-05-03 WO disclosed
WO-2012032523-A2 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM REGENERA PHARMA LTD. (IL) 2012-03-15 WO disclosed
US-20120039992-A1 COMPOSITIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD. (IL) 2012-02-16 US disclosed
EP-2403512-A2 Compositions of polymeric myrcene Regenera Pharma Ltd. (IL) 2012-01-11 EP disclosed
EP-2403505-A2 THERAPEUTIC USES OF MASTIC GUM FRACTIONS Regenera Pharma Ltd. (IL) 2012-01-11 EP disclosed
US-20120003175-A1 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD. (IL) 2012-01-05 US disclosed
WO-2011051945-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES REGENERA PHARMA LTD. (IL) 2011-05-05 WO disclosed
US-20100298489-A1 FLAME-RESISTANT SEALING MATERIAL KREIDEWERK JOSEF RAMSAUER KG (AT) 2010-11-25 US disclosed
WO-2010100650-A2 THERAPEUTIC USES OF MASTIC GUM FRACTIONS REGENERA PHARMA LTD. (IL) 2010-09-10 WO disclosed
WO-2010100651-A2 COMPOSITIONS OF POLYMERIC MYRCENE REGENERA PHARMA LTD. (IL) 2010-09-10 WO disclosed
US-20100105803-A1 COMPOSITION AND METHOD CRODA UNIQEMA INC. (US) 2010-04-29 US disclosed
US-20090317485-A1 Skin Protectant Spray Compositions HEALY MICHAEL SEAN 2009-12-24 US disclosed
US-20090311207-A1 ENHANCED PHOTOCONDUCTIVITY AND SPF OF SEMICONDUCTORS PLAYTEX PRODUCTS, INC. 2009-12-17 US disclosed
EP-2132251-A2 COMPOSITION AND METHOD Croda Uniqema Inc (US) 2009-12-16 EP disclosed
EP-1421139-B1 HIGHER ALKYLATED TRIARYL PHOSPHATE ESTER FLAME RETARDANTS CHEMTURA CORP (US) 2009-10-21 EP disclosed
US-20090208647-A1 Method for producing a funtional, high-energy material NITROCHEMIE WIMMIS AG (CH) 2009-08-20 US disclosed
US-20080233067-A1 Method Of Making Enhanced Efficacy Antiperspirant Actives COLGATE-PALMOLIVE COMPANY (US) 2008-09-25 US disclosed
WO-2008079304-A2 COMPOSITION AND METHOD CRODA UNIQEMA, INC. (US) 2008-07-03 WO disclosed
US-7332461-B2 Anionic surfactants CRODA INTERNATIONAL PLC (GB) 2008-02-19 US disclosed
US-7285519-B2 Oil production additive formulations CRODA INTERNATIONAL PLC (GB) 2007-10-23 US disclosed
US-7285519-B2 Oil production additive formulations CRODA INTERNATIONAL PLC (GB) 2007-10-23 US disclosed
US-20070022587-A1 Process for creating fabrics with branched fibrils MYERS KASEY R 2007-02-01 US disclosed
US-20070020455-A1 Process for creating fabrics with branched fibrils and such fibrillated fabrics SAGE AUTOMOTIVE INTERIORS, INC. 2007-01-25 US disclosed
EP-1286652-B1 SKIN PROTECTANT SPRAY COMPOSITIONS PFIZER PROD INC (US) 2006-09-06 EP disclosed
US-20060166578-A1 Process for creating fabrics with branched fibrils and such fibrillated fabrics MILLIKEN & COMPANY 2006-07-27 US disclosed
WO-2006078835-A1 PROCESS FOR CREATING FABRICS WITH BRANCHED FIBRILS AND SUCH FIBRILLATED FABRICS MILLIKEN & COMPANY (US) 2006-07-27 WO disclosed
EP-1235888-B1 Procédé pour traiter le pétrole brut ou l'huile dans un processus de raffinage ICI PLC (GB) 2005-12-21 EP disclosed
EP-1235888-B1 Procédé pour traiter le pétrole brut ou l'huile dans un processus de raffinage ICI PLC (GB) 2005-12-21 EP disclosed
US-20050266035-A1 Skin protectant spray compositions PFIZER INC. 2005-12-01 US disclosed
CN-1226393-C Oil production additive formulations ICI PLC (GB) 2005-11-09 CN disclosed
US-6949249-B2 Mixture contains flow control agent and thickener PFIZER INC. (US) 2005-09-27 US disclosed
US-20040152606-A1 Anionic surfactants IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2004-08-05 US disclosed
EP-1421139-A2 HIGHER ALKYLATED TRIARYL PHOSPHATE ESTER FLAME RETARDANTS Pabu Services, Inc. (US) 2004-05-26 EP disclosed
EP-1381347-A1 ANTIPERSPIRANT ACTIVES FROM A GLASS FORM AND PRODUCTS MADE THEREWITH Colgate-Palmolive Company (US) 2004-01-21 EP disclosed
US-6667355-B2 Adding a mixture comprising triaryl phosphate esters to polyurethane for imparting flame retardant properties PABU SERVICES, INC. 2003-12-23 US disclosed
EP-1360266-A1 A METAL WORKING LUBRICANT COMPOSITION Imperial Chemical Industries PLC (GB) 2003-11-12 EP disclosed
US-20030082223-A1 Skin protectant spray compositions JOHNSON & JOHNSON CONSUMER COMPANIES, INC 2003-05-01 US disclosed
US-20030079879-A1 Maintenance of oil production and refining equipment IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2003-05-01 US disclosed
US-20030078325-A1 Higher alkylated triaryl phosphate ester flame retardants CHEMTURA USA CORPORATION 2003-04-24 US disclosed
CN-1409752-A Oil production additive formulations ICI PLC (GB) 2003-04-09 CN disclosed
US-20030051395-A1 Oil production additive formulations IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2003-03-20 US disclosed
US-20030051395-A1 Oil production additive formulations IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2003-03-20 US disclosed
EP-1292274-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES Colgate-Palmolive Company (US) 2003-03-19 EP disclosed
WO-2003020809-A2 HIGHER ALKYLATED TRIARYL PHOSPHATE ESTER FLAME RETARDANTS PABU SERVICES, INC. (US) 2003-03-13 WO disclosed
EP-1286652-A2 SKIN PROTECTANT SPRAY COMPOSITIONS Pfizer Products Inc. (US) 2003-03-05 EP disclosed
EP-1276828-A1 MAINTENANCE OF OIL PRODUCTION AND REFINING EQUIPMENT Imperial Chemical Industries PLC (GB) 2003-01-22 EP disclosed
WO-2002085321-A1 ANTIPERSPIRANT ACTIVES FROM A GLASS FORM AND PRODUCTS MADE THEREWITH COLGATE-PALMOLIVE COMPANY (US) 2002-10-31 WO disclosed
EP-1235888-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2002-09-04 EP disclosed
EP-1235888-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2002-09-04 EP disclosed
WO-2002064712-A1 A METAL WORKING LUBRICANT COMPOSITION IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2002-08-22 WO disclosed
US-6342210-B1 POURING AQUEOUS SOLUTION OF ALUMINUM OR ALUMINUM ZIRCONIUM SALTS ONTO BOUNDED FLAT SURFACE, EVAPORATING SOLVENT TO FORM GLASS, BREAKING UP GLASS, MIXING WITH NON-AQUEOUS LIQUID VEHICLE IN WHICH SALT IS NOT SOLUBLE, HOMOGENIZING, GRINDING COLGATE-PALMOLIVE COMPANY 2002-01-29 US disclosed
WO-2001097768-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES COLGATE-PALMOLIVE COMPANY (US) 2001-12-27 WO disclosed
WO-2001085128-A2 SKIN PROTECTANT SPRAY COMPOSITIONS PFIZER PRODUCTS INC. (US) 2001-11-15 WO disclosed
WO-2001074966-A1 MAINTENANCE OF OIL PRODUCTION AND REFINING EQUIPMENT IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2001-10-11 WO disclosed
WO-2001074977-A2 LUBRICANT AND FLUSHING COMPOSITIONS ICI AMERICAS INC. (US) 2001-10-11 WO disclosed
WO-2001040412-A1 PETROLEUM FUEL ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2001-06-07 WO disclosed
WO-2001040410-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2001-06-07 WO disclosed
WO-2001040410-A1 OIL PRODUCTION ADDITIVE FORMULATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 2001-06-07 WO disclosed
EP-1061125-A2 Composition containing di(2-ethylhexyl) adipate and tricyclic isochroman compounds and use thereof in enzyme-active detergents and fabric softeners INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2000-12-20 EP disclosed
US-5961998-A Glossy composition containing aromatic oils thickened by a polysaccharide ether L'OREAL (FR) 1999-10-05 US disclosed
US-5550015-A PRECIPITATING A SILVERBROMOIODIDE CORE BY DOUBLE JET METHOD; RIPENING; GROWING GRAINS BY ADDING SILVER IONS FROM ONE SOLUTION AND BROMIDE AND IODIDE IONS FROM ANOTHER AGFA-GEVAERT AG (DE) 1996-08-27 US disclosed
US-5462843-A Silver halide emulsion doped with at least one metal compound AGFA-GEVAERT AG (DE) 1995-10-31 US disclosed
US-5445928-A Improved reproduction at high density with excellent color separation; using gap sensitizer in coupler-free layer containing silver halide emulsion AGFA-GEVAERT AG (DE) 1995-08-29 US disclosed
US-5407789-A Sharpness, graininess AGFA-GEVAERT AG (DE) 1995-04-18 US disclosed
US-5385813-A A green-photosensitive silver halide emulsion containing a magenta coupler a phenyl amidosulfonyl benzothiazoles; adjust to any desired sensitivity AGFA-GEVAERT AG (DE) 1995-01-31 US disclosed
US-5360704-A Color photographic recording material AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1994-11-01 US disclosed
US-5354649-A Silver halide emulsion of silver chloride and silver iodide and a coupler AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1994-10-11 US disclosed
US-5306605-A Improved sharpness AGFA-GEVAERT AG 1994-04-26 US disclosed
US-5266451-A Spectrally sensitized silver halide emulsion AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1993-11-30 US disclosed
CN-1021229-C CATALYST FOR OLEFINIC POLYMERIZATION AND PROCESS FOR OLEFINIC POLYMERIZATION MITSUI PETROCHEMICAL IND (JP) 1993-06-16 CN disclosed
US-5215875-A Coupler layer containing at least one para-phenylenediamine compound; intensification with hydrogen peroxide AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1993-06-01 US disclosed
US-5200301-A COLOR PHOTOGRAPHIC RECORDING MATERIAL AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1993-04-06 US disclosed
US-5143823-A N-Acylsulfamoyl-Substituted A-Acylacetanilide Yellow Coupler AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1992-09-01 US disclosed
US-5134061-A Nondiffusing \"building blocks\" (couplers, development inhibitors etc.) having a sulfonamide group and a secondary branched alkyl of 14 carbons or more; low-melting; crystal growth inhibitors; high-density color AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1992-07-28 US disclosed
US-5134059-A Magenta pyrazolone couplers BAYER AKTIENGESELLSCHAFT (DE) 1992-07-28 US disclosed
US-5089381-A SILVER HALIDE RECORDING MATERIAL AGFA-GEVAERT AG (DE) 1992-02-18 US disclosed
US-5006457-A Triazole derivatives as antifogging agents BAYER AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
US-4992362-A Precipitation of silver halide in presence of gelatin; uniform grain distribution AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1991-02-12 US disclosed
US-4978607-A CONTAINING GELATIN, MODIFIED WITH MONOFUNCTIONAL ACID DERIVATIVE, AND HARDENER, A CARBAMOYL PYRIDINIUM SALT; WITHOUT RETICULATED GRAIN AGFA-GEVAERT AKTIENGESSELLSCHAFT (DE) 1990-12-18 US disclosed
CN-1042156-A The polymerization process of catalyst for olefines polymerizing composition and preparation method thereof, catalyst for olefines polymerizing and alkene MITSUI PETROCHEMICAL IND (JP) 1990-05-16 CN disclosed
EP-0099026-B1 PROCESS FOR PREPARING SOLID TITANIUM TRICHLORIDE USEFUL FOR THE POLYMERIZATION OF AN ALPHA-OLEFIN MITSUBISHI KASEI CORPORATION (JP) 1986-12-30 EP disclosed
US-4534953-A PRECIPITATION OF VIOLET PARTICLES BEFORE ADDING TITANIUM TETRACHLORIDE AND AGING MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1985-08-13 US disclosed
US-4442224-A STEREOSPECIFIC TOYO STAUFFER CHEMICAL CO., LTD. (JP) 1984-04-10 US disclosed
US-4442225-A Catalytic component for polymerization of α-olefin and method for homo- or co-polymerization of α-olefin TOYO STAUFFER CHEMICAL CO., LTD. (JP) 1984-04-10 US disclosed
EP-0102503-A2 Process for producing a catalyst component used for the polymerization of alpha-olefins TOYO STAUFFER CHEMICAL CO. LTD. (JP) 1984-03-14 EP disclosed
EP-0099026-A2 Process for preparing solid titanium trichloride useful for the polymerization of an alpha-olefin MITSUBISHI KASEI CORPORATION (JP) 1984-01-25 EP disclosed
US-4305920-A FOR POLYMERIZATION CATALYST MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-15 US disclosed
US-4305920-A FOR POLYMERIZATION CATALYST MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (17 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11207333-B2 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy AQP4, CYP27A1, PMP22 ALDH1A1 1999/4885TSHR 2119/4885LMNA 3274/4885
US-11173164-B2 Compositions comprising triterpenoids PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-20190224216-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY OPA1, PMP22, GANAB ALDH1A1 3014/4885TSHR 4762/4885LMNA 2587/4885
US-20190209582-A1 COMPOSITIONS COMPRISING TRITERPENOIDS PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-20200155569-A1 COMPOSITIONS COMPRISING TRITERPENOIDS PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-20190038529-A1 ODOR-REDUCING DEVELOPER FOR OXIDATION DYES II HAO2, SORD, AOX1 ALDH1A1 61/4885TSHR 4652/4885LMNA 1113/4885
US-20180264006-A1 COMPOSITIONS COMPRISING TRITERPENOIDS PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-20190224217-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY AQP4, CYP27A1, PMP22 ALDH1A1 1999/4885TSHR 2119/4885LMNA 3274/4885
US-20190314389-A1 COMPOSITIONS COMPRISING TRITERPENOIDS CYP27A1, CYP11B2, CYP11B1 ALDH1A1 2491/4885TSHR 1841/4885LMNA 1750/4885
US-11083736-B2 Compositions comprising triterpenoids CYP27A1, CYP11B2, CYP11B1 ALDH1A1 2491/4885TSHR 1841/4885LMNA 1750/4885
US-20160008291-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF IAPP, VIP, LNPEP ALDH1A1 4172/4885TSHR 2019/4885LMNA 4043/4885
US-20120213727-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES APP, SQLE, PTAR1 ALDH1A1 791/4885TSHR 4690/4885LMNA 86/4885
US-10751347-B2 Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy OPA1, PMP22, GANAB ALDH1A1 3014/4885TSHR 4762/4885LMNA 2587/4885
US-10285996-B2 Compositions comprising triterpenoids PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-10588911-B2 Compositions comprising triterpenoids PARK7, SNCA, APP ALDH1A1 3503/4885TSHR 4378/4885LMNA 3158/4885
US-20150079021-A1 THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES HSD3B1, HSD3B2, CYP17A1 ALDH1A1 740/4885TSHR 4619/4885LMNA 188/4885
US-20180256603-A1 COMPOSITIONS COMPRISING TRITERPENOIDS CYP27A1, CYP11B2, CYP11B1 ALDH1A1 2491/4885TSHR 1841/4885LMNA 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.